Table 3.

Univariate Analysis of Proportional Hazards Regression to Death, Cholangiocarcinoma or Liver Transplant

Characteristic	Hazard ratio (HR)	95% HR confidence interval	P-value
Gender	1.065	(0.515, 2.200)	0.87
Race	0.835	(0.3, 2.327)	0.73
White
Non-white
Age at diagnosis	1.029	(1.004, 1.054)	0.02
IBD	0.657	(0.315, 1.373)	0.26
No
Yes
Lab measurement at study entry
Sodium	1.144	(1.022, 1.28)	0.02
Creatinine	4.034	(1.116, 14.584)	0.03
Alkaline phosphatase	1.000	(0.999, 1.002)	0.47
Alanine aminotransferase	0.997	(0.993, 1.001)	0.14
Aspartate aminotransferase	0.996	(0.992, 1.001)	0.13
Bilirubin	1.122	(1.039, 1.211)	0.003
INR	1.569	(0.874, 2.818)	0.13
Albumin	1.013	(0.938, 1.095)	0.74
MELD	1.066	(0.998, 1.139)	0.06
Lab measurement at last entry
Sodium	0.941	(0.804, 1.101)	0.45
Creatinine	1.873	(0.711, 4.932)	0.20
Alkaline phosphatase	1.001	(0.999, 1.003)	0.51
Alanine aminotransferase	0.999	(0.992, 1.006)	0.76
Aspartate aminotransferase	1.000	(0.994, 1.006)	0.99
Bilirubin	1.09	(0.982, 1.210)	0.11
International normalized ratio	1.335	(0.440, 4.045)	0.61
Albumin	0.329	(0.153, 0.709)	0.005